prof. Agnieszka Dobrzyń
Director of Nencki Institute of Experimental Biology PAS
Director of Nencki Institute of Experimental Biology PAS, Head of the Laboratory Of Cell Signaling an Metabolic Disorders, Nencki Institute PAS, Director of SARK-Poland (translational scientist without borders); Advisory Board member of Polish Science Contact Agency (PolSCA) in Brussels. Selected experience: Master of Science, 1997, Warsaw University, Poland; PhD in Medical Sciences, 2001, Medical University of Bialystok, Poland; Habilitation in Medical Sciences, 2006, Medical University of Bialystok, Poland; Professor of Biological Sciences, 2015, Nencki Institute PAS, Poland, nomination by the President of the Republic of Poland; Post-doc (2002-06): Department of Biochemistry, University of Wisconsin-Madison, USA; Prof. Dobrzyn is the author or co-author of 92 research publications, three book chapters, and 4 patents, incl. the method for the early diagnosis of a pre-diabetic state and type 2 diabetes' (US 10222384, PCT/IB2016/051087) and flow microsystem for the creation, culture and fluorescent imaging of three-dimensional aggregates of pancreatic island cells for the treatment of type 1 diabetes (P.431667). For her work prof. Dobrzyn received the Minister of Science and Higher Education award for outstanding scientific achievements, twice in 2016 and 2020. Since September 2020, Prof. Agnieszka Dobrzyń has been the National Coordinator for mass testing for SARS-CoV-2 and the head of the SONAR project, which aims to develop and implement COVID-19 pooled testing in Poland.